Imipenem

EsbL ; Escherichia coli







46 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 34161207 Antimicrobial Resistance in Bacteria Causing Urinary Tract Infections. 2022 1
2 33691795 Prevalence of multidrug-resistant and extended-spectrum beta-lactamase producing Gram-negative isolates from clinical samples in a tertiary care hospital of Nepal. 2021 Mar 11 1
3 33888997 Antimicrobial Surveillance for Bacterial Uropathogens in Ha'il, Saudi Arabia: A Five-Year Multicenter Retrospective Study. 2021 1
4 32712107 Incidence and antimicrobial profile of extended-spectrum β-lactamase producing gram-negative bacterial isolates: An in-vitro and statistical analysis. 2020 Nov 1
5 30917252 [Sensitivity and resistance to antimicrobial agents ESBL-producing and not producing ESBL strains of E. coli in patients with urinary tract infection.] 2019 1
6 31118698 Susceptibilities of Gram-negative bacilli from hospital- and community-acquired intra-abdominal and urinary tract infections: a 2016-2017 update of the Chinese SMART study. 2019 4
7 31949454 Prevalence and antibiotic resistance pattern of extended-spectrum beta-lactamase-producing Escherichia coli in clinical specimens. 2019 2
8 33536830 Trend in Antibiotic Resistance of Extended-Spectrum Beta-Lactamase-Producing Escherichia Coli and Klebsiella Pneumoniae Bloodstream Infections. 2019 2
9 30033423 Phenotypic expression and prevalence of multi drug resistant extended spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae in Karachi, Pakistan. 2018 Jul 1
10 30532496 Detection, characterization, and antibiogram of extended-spectrum beta-lactamase Escherichia coli isolated from bovine milk samples in West Bengal, India. 2018 Nov 1
11 28368864 Characterization of ESBL-producing Escherichia coli recovered from companion dogs in Tai'an, China. 2017 Mar 31 1
12 28934938 Shifting trends in bacteriology and antimicrobial resistance among gastrointestinal fistula patients in China: an eight-year review in a tertiary-care hospital. 2017 Sep 21 2
13 27790433 Prevalence of ESBL in Escherichia coli Isolates Among ICU Patients in a Tertiary Care Hospital. 2016 Sep 1
14 25600841 Carbapenem susceptibility among Escherichia coli, Klebsiella pneumoniae, and Enterobacter cloacae isolates obtained from patients in intensive care units in Taiwan in 2005, 2007, and 2009. 2015 Apr 1
15 25649300 Impact of carbapenem heteroresistance among clinical isolates of invasive Escherichia coli in Chongqing, southwestern China. 2015 May 1
16 26120573 Prevalence and Genotypic Characterization of Extended-Spectrum Beta-Lactamases Produced by Gram Negative Bacilli at a Tertiary Care Hospital in Rural South Western Uganda. 2014 Dec 2
17 23439636 Inoculum effect on the efficacies of amoxicillin-clavulanate, piperacillin-tazobactam, and imipenem against extended-spectrum β-lactamase (ESBL)-producing and non-ESBL-producing Escherichia coli in an experimental murine sepsis model. 2013 May 1
18 23607946 [Species and drug resistance of pathogens in blood cultures from the pediatric hematology ward]. 2013 Apr 3
19 23741022 A 10 year surveillance for antimicrobial susceptibility of Escherichia coli and Klebsiella pneumoniae in community- and hospital-associated intra-abdominal infections in China. 2013 Sep 1
20 23742831 Evaluation of the in vitro activity of fosfomycin tromethamine against Gram-negative bacterial strains recovered from community- and hospital-acquired urinary tract infections in Turkey. 2013 Nov 1
21 24502096 [Prevalence and antimicrobial susceptibility of extended-spectrum beta-lactamase producing urinary isolates of Escherichia coli in outpatients]. 2013 Nov-Dec 2
22 22220506 Antimicrobial susceptibility of gram-negative pathogens isolated from patients with complicated intra-abdominal infections in South African hospitals (SMART Study 2004-2009): impact of the new carbapenem breakpoints. 2012 Feb 1
23 22546718 Low frequency of ertapenem-resistant intra-abdominal isolates of Escherichia coli from Latin America: susceptibility, ESBL-occurrence, and molecular characterisation (SMART 2008-2009). 2012 Feb 1
24 22808728 [Occurrence of alert pathogens in hospital environment. Part I. ESBL-producing enterobacteriaceae strains]. 2012 1
25 23198454 In vitro activity of fosfomycin and other antimicrobials against uropathogenic Escherichia coli and Klebsiella pneumoniae at a tertiary care center in Lebanon. 2012 Jul-Sep 1
26 27418912 Prevalence of extended spectrum beta-lactamase production among uropathogens in south Mumbai and its antibiogram pattern. 2012 1
27 21183602 Extended-spectrum beta-lactamase-producing Gram-negative bacteria causing neonatal sepsis in India in rural and urban settings. 2011 Apr 1
28 21323503 Comparison of in vitro activity of ertapenem with other carbapenems against extended-spectrum beta-lactamase-producing Escherichia coli and Kleibsella species isolated in a tertiary children's hospital. 2011 Apr 1
29 21751604 Incidence of ESBL producers amongst Gram-negative bacilli isolated from intra-abdominal infections across India (based on SMART study, 2007 data). 2011 May 1
30 19800278 Refractory vertebral osteomyelitis due to CTX-M-14-producing Escherichia coli at ertapenem treatment in a patient with a coexisting urinary tract infection caused by the same pathogen. 2010 Sep 1
31 20728316 Epidemiology and antimicrobial susceptibility profiles of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections in the Asia-Pacific region: 2008 results from SMART (Study for Monitoring Antimicrobial Resistance Trends). 2010 Nov 1
32 20818104 Nosocomial blood-stream infections from extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumonia from GB Pant Hospital, New Delhi. 2010 Sep 3 1
33 19464043 Incidence of acute prostatitis caused by extended-spectrum beta-lactamase-producing Escherichia coli after transrectal prostate biopsy. 2009 Jul 2
34 18059098 Prevalence and antimicrobial susceptibility pattern of extended-spectrum beta-lactamase-producing Enterobacteriaceae in the United Arab Emirates. 2008 1
35 18060745 Prevalence of extended-spectrum beta-lactamase-producing Escherichia coli in a tertiary care hospital in Tehran, Iran. 2008 Feb 1
36 18518776 In vitro activity of ertapenem and other carbapenems against extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae clinical isolates in a tertiary care center in Turkey. 2008 Jun 2
37 18953872 [Prevalence of extended-spectrum beta-lactamase producing Escherichia coli in pediatric patients in China]. 2008 May 27 1
38 19579719 Prevalence of extended spectrum beta-lactamases producing clinical isolates from patients of urinary tract infection in a tertiary care hospital in Delhi. 2008 Dec 1
39 16930951 Pharmacodynamic profiling of imipenem, meropenem and ertapenem against clinical isolates of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. from Brazil. 2006 Oct 1
40 15949189 Prevalence of the genes encoding extended-spectrum beta-lactamases, in Escherichia coli resistant to beta-lactam and non-beta-lactam antibiotics. 2005 Jun 1
41 15983682 Extended-spectrum beta-lactamases in urinary isolates of Escherichia coli, Klebsiella pneumoniae and other gram-negative bacteria in a hospital in Eastern Province, Saudi Arabia. 2005 Jun 1
42 16360549 Prevalence and antimicrobial susceptibility data for extended-spectrum beta-lactamase- and AmpC-producing Enterobacteriaceae from the MYSTIC Program in Europe and the United States (1997-2004). 2005 Dec 1
43 17642726 Extended spectrum -lactamases in urinary isolates of Escherichia coli and Klebsiella pneumoniae - prevalence and susceptibility pattern in a tertiary care hospital. 2004 Jul-Sep 1
44 11929691 Prevalence of extended spectrum beta-lactamase (ESBL)-producing clinical isolates in the Asia-Pacific region and South Africa: regional results from SENTRY Antimicrobial Surveillance Program (1998-99). 2002 Mar 1
45 11320450 Variations in the prevalence of strains expressing an extended-spectrum beta-lactamase phenotype and characterization of isolates from Europe, the Americas, and the Western Pacific region. 2001 May 15 1
46 7871780 [A novel extended-spectrum beta-lactamase in a ceftazidime-resistant isolate of E. coli]. 1994 Oct 2